Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
Article in Breast Cancer Research and Treatment (May 2023)
The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.
Therapeutic Efficacy of Roscovitine Against Cancer
Book chapter (September 2022)
A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer.
Article in Cancer Research (August 2022)